Limerston Capital sells controlling stake in Prism Healthcare to Charme Capital Partners

Feb 12, 2022

Limerston Capital portfolio company Arch Sciences sold to Element

Jul 14, 2021

News

Back to the top

Quick Links

Investing Responsibly

News

Careers

Contact Us

About Limerston Capital

Limerston Capital is a private equity firm with over £500 million under management. We target UK businesses valued at £20 - £200 million, partnering with management teams to help build them into industry leaders.

We differentiate by providing strong operational and acquisition support to our companies through our fully-integrated and dedicated operational and investment teams.

Regulatory Disclosure

Terms & Conditions

Privacy Policy

Modern Slavery

Limerston Capital is authorised and regulated by the Financial Conduct Authority.

About Us
Our People
Our Portfolio
Responsible Investing
News
Contact

bottom of page